What it is
Ipamorelin is an investigational growth-hormone secretagogue that interacts with the ghrelin receptor. Online marketing commonly links it to body composition, recovery, sleep, or anti-aging.
What the evidence can tell us
Pharmacology and early clinical research can show that a compound changes hormone levels without establishing that it improves meaningful health outcomes. Mechanistic activity is not proof of a favourable benefit–risk balance.
Canadian context
Health Canada’s April 2026 advisory names ipamorelin as an unauthorized injectable peptide drug. No authorized ipamorelin drug product was identified in the Drug Product Database on the date checked.
Key unknowns
Long-term safety, clinically meaningful benefit, interactions, and risks in people with underlying conditions are not established. Unauthorized online products also introduce uncertainty about formulation, concentration, and sterility.
Source trail